Clinical Research Site
Cincinnati, Ohio 45245
5 studies enrolling now · 17 studies all time
What they study most
ADHD, Agitation in Patients With Dementia of the Alzheimer's Type, Binge-Eating Disorder, Cataplexy, Depression, Essential Hypertension, Excessive Daytime Sleepiness, Excessive Sleepiness, Major Depressive Disorder, Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms, Migraine, Narcolepsy
Studies at this site
- Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol — Recruiting now
- Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol — Recruiting now
- Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN) — Recruiting now
- A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms — Recruiting now
- A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy — Completed
- A Study to Assess the Efficacy and Safety of Solriamfetol in Subjects With ADHD (FOCUS) — Completed
- Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE) — Stopped early
- Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol — Completed
- Open-Label Safety Study of Solriamfetol in Subjects With Binge Eating Disorder — Enrolling by invitation
- A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE) — Completed
- Multimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT) — Completed
- Maximizing Outcomes in Treating Acute Migraine — Completed
- Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type — Completed
- Open-Label Safety Study of AXS-05 in Subjects With Depression — Completed
- A Trial of AXS-05 in Patients With Major Depressive Disorder — Completed
- Mechanistic Evaluation of Response in TRD (MERIT) — Completed
- An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension — Completed